Home688513 • SHA
add
Chengdu Easton Biopharmaceuticals Co Ltd
Previous close
ÂĄ31.17
Day range
ÂĄ30.95 - ÂĄ31.54
Year range
ÂĄ28.11 - ÂĄ46.84
Market cap
5.40B CNY
Avg Volume
1.69M
P/E ratio
21.71
Dividend yield
1.27%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 308.36M | 15.35% |
Operating expense | 501.10M | 118.32% |
Net income | 19.54M | -40.53% |
Net profit margin | 6.34 | -48.41% |
Earnings per share | — | — |
EBITDA | 58.80M | 628.66% |
Effective tax rate | -8.06% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.41B | -7.47% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 2.68B | — |
Shares outstanding | 170.72M | — |
Price to book | 2.03 | — |
Return on assets | — | — |
Return on capital | 3.58% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 19.54M | -40.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Jun 1, 2009
Website
Employees
1,481